Effects of high-dose intravenous methylprednisolone in children with acute rheumatic carditis

Pediatrics International

Volumn 38, Issue 1, 1996, Pages 28-31

  Akçoral, Adnan ^a   Oran, Bülent ^b   Tavli, Vedide ^a   Ünal, Nurettin ^a   Çevik, Necla T ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

Author keywords

Intravenous pulse therapy; Methylprednisolone; Rheumatic carditis

Indexed keywords

METHYLPREDNISOLONE;

AORTA VALVE REGURGITATION; ARTICLE; CARDITIS; CHILD; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DOSE RESPONSE; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; MITRAL VALVE REGURGITATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PULSE RATE; RHEUMATIC HEART DISEASE; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; PREDNISOLONE; RHEUMATIC HEART DISEASE;

EID: 0029886429     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1996.tb03430.x     Document Type: Article

References (23)

1. Human DG, Hill ID, Fraser GB. Treatment choice in acute rheumatic carditis. Arch. Dis. Child. 1984; 59: 410–13.
2. Daniel PS. Acute rheumatic fever. In: Daniel PS, Abbal IT. (eds): Basic and Clinical Immunology. East-Norwalk, Lanfe Medical Publications, 1991; 640–1.
3. Kaplan EL. Rheumatic fever. In: Behrman RE, Kliegman RM, Nelson WE, Vaughan VC III (eds) Nelson Textbook of Pediatrics. 14th edn. Philadelphia, WB Saunders, 1992; 640–5.
4. Akçoral A., Aslin MI, Narin N. High-dose intravenous methylprednisolone for treatment of children with acute rheumatic carditis. Doǧa-Tr. J. Med. Sci. 1992; 16: 175–82.
5. Hammerschmidt DE, White JG, Carrock PR et al. Corticosteroid inhibits complement-induced granulocyte aggregation: A possible mechanism for their efficacy in shock states. J. Clin. Invest. 1979; 63: 798–803.
6. Baylis EM, Willians IA, English J. et al. High-dose intravenous methylprednisolone ‘pulse’ therapy in patients with rheumatoid disease. Eur. J. Clin. Pharmacol. 1982; 21: 385–8.
7. Özsoylu Ş. High-dose intravenous methylprednisolone for idiopathic myelofibrosis. Lancet 1988; 2: 766.
8. Smith MD, Ahem MJ, Roberts PJ. Pulse steroid therapy in rheumatoid arthritis. Ann. Rheum. Dis. 1988; 47: 28–33.
9. Dajani AS, Ayoub E., Bierman FZ et al. Guidelines for the diagnosis of rheumatic fever: Jones Criteria. J. Am. Med. Assoc. 1991; 268: 2069–73.
10. Ayoub EM, Barrett DJ. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J. Clin. Invest. 1986; 77: 2019–26.
11. Tsune YW, Chang AC, Chin AJ. Semiquantitative assessment of mitral regurgitation by Doppler color flow imaging in patients aged < 20 years. Am. J. Cardiol. 1993; 71: 727–32.
12. Kraft N., Thomson NM. Modulation of human mitogen response by methylprednisolone, role of macrophage. Transplantation 1979; 28: 275–9.
13. Krajevski AS, Wylline AH. Inhibition of human T-lymphocyte colony formation by methylprednisolone. Clin. Exp. Immunol. 1981; 46: 206–13.
14. Gillins S., Crabtree GR, Smith KA. Glucocorticoid-induced inhibition of T-cell growth factor production. The effect on mitogen-induced lymphocyte proliferation. J. Immunol. 1979; 123: 1624–31.
15. Duncan FJ, Amorosino CS. High-dose corticosteroids for septic shock. N. Engl. J. Med. 1984; 1: 1178–9.
16. Lozman J., Dutton RE, Englis M. et al. Cardiopulmonary adjustments following single high-dose administration of methyl-prednisolone in traumatized man. Ann. Surg. 1975; 181: 317–24.
17. Hammerman H., Robert KD, Kloner RA et al. Dose-dependent effects of short term methylprednisolone on myocardial infarct extent scar formation, ventricular function. Circulation 1983; 468: 446–52.
18. Derek, Stubbs F. Post acute myocardial infarction symptomatic pericardis: Report on a large series and the effect of methylprednisolone therapy. J. Int. Med. Res. 1986; 14 (Suppl 1): 25–9.
19. Couto AA, Martin JCS, Mansur EM et al. Methylprednisolone intravenous en altas doses (pulsoterapia): Possivel soluçao terapeutica para a febre reumatica ativa com cardite grave. Arg. Bras. Cardiol. 1984; 43: 97–101.
20. Couto AA, Oliveria GEM, Campos AI et al. Duraçaoda atividade reumatica em pacientes tratados com corticoide oral pulsoterapia. Arg. Bras. Cardiol. 1987; 48: 371–3.
21. Smith MD, Ahern MJ, Thomson PR. Pulse steroid therapy in rheumatoid arthritis: Can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? Ann. Rheum. Dis. 1988; 47: 28–33.
22. Ozsoylu Ş. High-dose intravenous methylprednisolone (HIVMP) in haematologic disorders. Hematol. Rev. 1990; 4: 197–207.
23. Daniel WW. Biostatistics: A foundation for analysis in the Health Sciences. 5th edn. New York, John Wiley, 1991.